[PDF] Top 20 Moderated Poster Session V: Oncology 2
Has 10000 "Moderated Poster Session V: Oncology 2" found on our website. Below are the top 20 most common "Moderated Poster Session V: Oncology 2".
Moderated Poster Session V: Oncology 2
... Background: Improved prostate cancer (CaP) detection using targeted Magnetic Resonance Imaging-Ultrasound (MRI-US) fusion compared to conventional biopsy has been shown in patients with repeat prostate biopsies. In this ... See full document
6
Moderated Poster Session V: Oncology 2
... Results: A total of 110 urologists responded (17% response rate) to the survey, although the email blast also included pediatric and retired urolo- gists. While 51% of respondents were <45 years of age, 18% were ... See full document
6
Moderated Poster Session II: Reconstruction/Andrology
... Results: From August 2012 to September 2015, 12 patients were random- ized into one of the two groups. The bed rest group consisted of four patients while the early ambulation group consisted of eight. Median age overall ... See full document
7
Moderated Poster Session 8: Miscellaneous
... By 2 weeks and 3 months postoperatively, the difference in QOL scores between the 2 groups disappeared (p = ...the 2 groups (p = ...group 2 experienced an ileus; there were no conversions and ... See full document
5
Moderated Poster Session 1: Prostate Cancer
... Methods and Materials: We present a series of treatment plans for patients with renal transplantation who developed prostate cancer and were treat- ed with radical radiation therapy using IMRT technique delivered via ... See full document
5
Moderated Poster Session 1: Basic Science
... Methods: Utilizing the subrenal prostatic recapitulation model for tis- sue recombination, rat urogenital mesenchyme (rUGM) was microdis- sected from rat embryos and combined with 10-20 mg slivers of prostate tumor or ... See full document
7
Moderated Poster Session 2: Functional Urology
... GRA scale. There was mild improvement in additional 55 patients (20.2 %). Ninety-three patients (34.3%) decided to stop taking the medica- tion for various reasons. The most common reason to stop the medica- tion was ... See full document
5
Moderated Poster Session VI: Education
... Methods: Men with localized prostate cancer who received care from 2007‒2013 at Dartmouth-Hitchcock Medical Center Oncology clinics were included in the study (N=411). All subjects received an information packet ... See full document
7
Moderated Poster Session 2: Basic Research
... Materials and Methods: Patients were stratified according to suspected depth of tumor invasion (< T1, > T2). The primary endpoint was reduc- tion in activation of the epidermal growth factor receptor (EGF-R) as ... See full document
7
Moderated Poster Session 5: Pediatric Urology
... Results: Three bilateral synchronous, 1 bilateral staged and 6 unilateral RPNs were performed. Mean operating times were 174 min (range 115- 250) for unilateral and 454 min (range 370-575) for bilateral RPNs, including 1 ... See full document
6
Moderated Poster Session 8: Kidney Cancer
... Introduction and Objective: Sunitinib is an established treatment for metasta- tic renal cell carcinoma (RCC). Neoadjuvant sunitinib may facilitate surgi- cal resection by reducing primary tumor size and may decrease ... See full document
5
Moderated Poster Session III: Pediatrics/Voiding Dysfunction
... Results: Overall, times were recorded for 129 patients. For the four sur- geons, overall mean OR efficiency ranged from 38‒44%. The overall mean OR utilization for each surgeon ranged from 63‒75%. There were 45 late ... See full document
8
Moderated Poster Session 6: Pediatric Urology
... Results: Four patients (22%) with suspected major vascular injuries required nephrectomy 1–21 days following the trauma. Two patients required selec- tive lower pole arterial embolization (11%). Three patients (17%) had ... See full document
6
Moderated Poster Session 7: General Urology
... Materials and Methods: Among the 103 women having SUI, 60 were assigned to Composix™, 21 to TVT™, and 22 to TVT-O™. patients pre- senting a complete set of data were included in the analysis. Preoperative workup included ... See full document
6
Moderated Poster Session 2: Kidney Cancer
... follow up was 7.8 months (2-11). Tumor size averaged 3.2 cm (0.9-6.5). Tumors were peripheral and exophytic in 8 and hilar in 5 patients. Average R.E.N.A.L. nephrometry score was 7.7 (5-11). A total of 13 lesions ... See full document
6
Moderated Poster Session 4: Bladder Cancer
... Materials and Methods: We collected and pooled a database of 2,287 patients who have undergone radical cystectomy for carcinoma of the bladder between 1993 and 2008 in 8 different centers across Canada. Complete ... See full document
6
Moderated Poster Session 2: Basic Science
... Methods: We included 290 patients from three university hospitals (Dallas, N=132; Toronto, N=104; Turku, N=54) who underwent radical cystectomy with at least a bilateral pelvic lymph-adenectomy. Patients who received ... See full document
8
Moderated Poster Session 6: Oncology
... including 2 cases called “desperation” procedures when the markers were still raising instead the use of appropriate sys- temic ...from 2 to 4 ...between 2 and 156 months with a mean of 47 months. ... See full document
6
Moderated Poster Session 3: Oncology II
... Background: Deleterious bladder effects after radical prostatectomy such as reduced compliance, decreased capacity, and hyperactivity influence recovery of urinary continence. NCT01371994 (Vanguard Trial) a multi- ... See full document
7
Moderated Poster Session 1: Oncology I
... Methods: A decision-analytic model was developed to compare costs and outcomes associated with four different prophylaxis strategies using inpatient hospital costs associated with VTE events and outpatient phar- ... See full document
10
Related subjects